Molecule intelOpportunity: StrongEssential

Iodine

84 brands · 57 companies · product forms

ATC: D08AG03 2 DRAP alerts

Opportunity snapshot

Launch attractiveness
52
Market saturation
87
Price room
100
Regulatory risk
70
84
brands
57
companies
Rs 313.81
median price
21
price points
148.54x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 5%

Price room

Across observed sources and strengths
CheapestRs 38
MedianRs 313.81
Most expensiveRs 5,644.66
Spread148.54×
Sources: DRAP-official, DVAGO

max/min price ratio 148.54x across 21 trusted points (Rs 38.0-5644.66). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 6 live products for Iodine — each links to its own medicine page.

Regulatory alerts

Recall exposureSafety exposurelatest 2026-03-11
17. Volunatry Recall. Osilex-D (Glitz Pharma)
Rapid Alert; Drug Product: Unregistered and Falsified Lipiodol Ultra Fluide 480mg/mL Injec

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(13) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

57 canonical companies and 84 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 148.54x across 21 trusted points (Rs 38.0-5644.66). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

2 DRAP alert(s), latest 2026-03-11 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.